Following intense negotiations, in March the House and Senate finally passed an appropriations package that funded the federal government for Fiscal Year (FY) 2022, which technically began October 1, 2021. The $1.5-trillion package received bipartisan support and follows months of advocacy by the Endocrine Society with increased funding for our priorities. The bill includes several important...
Biden Continues Focus on ARPA-H, Cancer Moonshot as Francis Collins Takes on New Role
President Joe Biden has named retired National Institutes of Health director Francis Collins to be the president’s top science adviser until permanent leadership is nominated and confirmed. Eric Lander who formerly led the Office of Science and Technology Programs (OSTP) and held the cabinet-level position of science adviser resigned after it became public that an...
Endocrine Society Advocates for Increased Funding for NIH Research, CDC
In another political nailbiter, with less than 24 hours remaining before all federal government funding would expire and cause a government shut-down, the U.S. Senate cleared legislation last month to continue funding the federal government through March 11. The temporary spending bill is the third such short-term funding bill for fiscal year (FY) 2022, which...
Congress Approves Continuing Resolution to Fund NIH Through February 18
With just hours to spare before its December 3 deadline, Congress averted a government shutdown and passed a continuing resolution (CR) that will fund the government at the previous year’s level through February 18, 2022. We appreciate the Endocrine Society members who participated in our online campaign, which helped avoid a destabilizing shutdown and ensured...
Advocacy Victory: EU Effectively Bans BPA in Food Contact Materials
The European Food Safety Administration (EFSA) issued a draft opinion in December that lowers the ‘tolerable daily intake of BPA in food contact materials by six orders of magnitude – effectively a ban on BPA and an advocacy victory for the Endocrine Society. We have called for better regulation of endocrine-disrupting chemicals in food contact materials. The Endocrine Society will provide supporting comments to...
Advocacy Victory: Congress Passes Legislation Averting Medicare Cuts
In December, Congress passed legislation to avert a series of Medicare cuts that would have resulted in an almost 10% reduction in Medicare payments to physicians. The Endocrine Society has been a vocal advocate for Congress to avert these alarming cuts, which were scheduled to occur in 2022, and we were pleased to see action...
For the seventh year running, Endocrine News talks to editors from Endocrine Society publications to get the endocrine discoveries of 2021 worth their weight in gold. Research never stops. Despite facing challenges related to social distancing, supply chain disruptions, and other pandemic-related problems this past year, scientists dug deep in the mines of endocrinology and...Endocrine Society Advocates for Increased Immunization Rates
With flu season in full swing, the Endocrine Society encourages its members to help “Raise the Rates” and increase adult immunization rates among their patients. Raise the Rates is an initiative led by the American College of Physicians (ACP) to help internists and other primary care providers in both understanding the immunization rates of their...
Endocrinology Advocacy
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
